Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mooi

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Infection and Immunity|May 25, 1999
Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in FinlandF R Mooi, Q He, H van Oirschot, et al.
Emerging Infectious Diseases|August 4, 2001
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?F R Mooi, I H van Loo, A J King
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2015
Complement evasion by Bordetella pertussis: implications for improving current vaccinesIlse Jongerius, Tim J Schuijt, Frits R Mooi, et al.
The Journal of Infectious Diseases|June 1, 1992
Fimbria-mediated adherence and hemagglutination of Haemophilus influenzaeS M van Ham, L van Alphen, F R Mooi
Journal of Bacteriology|May 1, 1982
Construction and characterization of mutants impaired in the biosynthesis of the K88ab antigenF R Mooi, C Wouters, A Wijfjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 23, 2010
[Pertussis in the Netherlands]Sabine C de Greeff, Hester E de Melker, Frits R Mooi
Nucleic Acids Research|March 1, 1979
Cloning, mapping and expression of the genetic determinant that encodes for the K88ab antigenF R Mooi, F K de Graaf, J D van Embden
Clinical Microbiology Reviews|September 11, 2015
Laboratory Diagnosis of PertussisAnneke van der Zee, Joop F P Schellekens, Frits R Mooi
Human Vaccines|February 27, 2009
Improving pertussis vaccinationGuy A M Berbers, Sabine C de Greeff, Frits R Mooi
FEMS Microbiology Letters|January 1, 1990
Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunitF R Mooi, A ter Avest, H G van der Heide
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Infection and Immunity|May 25, 1999
Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in FinlandF R Mooi, Q He, H van Oirschot, et al.
Emerging Infectious Diseases|August 4, 2001
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?F R Mooi, I H van Loo, A J King
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2015
Complement evasion by Bordetella pertussis: implications for improving current vaccinesIlse Jongerius, Tim J Schuijt, Frits R Mooi, et al.
The Journal of Infectious Diseases|June 1, 1992
Fimbria-mediated adherence and hemagglutination of Haemophilus influenzaeS M van Ham, L van Alphen, F R Mooi
Journal of Bacteriology|May 1, 1982
Construction and characterization of mutants impaired in the biosynthesis of the K88ab antigenF R Mooi, C Wouters, A Wijfjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 23, 2010
[Pertussis in the Netherlands]Sabine C de Greeff, Hester E de Melker, Frits R Mooi
Nucleic Acids Research|March 1, 1979
Cloning, mapping and expression of the genetic determinant that encodes for the K88ab antigenF R Mooi, F K de Graaf, J D van Embden
Clinical Microbiology Reviews|September 11, 2015
Laboratory Diagnosis of PertussisAnneke van der Zee, Joop F P Schellekens, Frits R Mooi
Human Vaccines|February 27, 2009
Improving pertussis vaccinationGuy A M Berbers, Sabine C de Greeff, Frits R Mooi
FEMS Microbiology Letters|January 1, 1990
Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunitF R Mooi, A ter Avest, H G van der Heide
Pageof 17